Detection of recurrent hepatocellular carcinoma on post-operative surveillance: Comparison of MDCT and gadoxetic acid-enhanced MRI

Abdominal Imaging

Volumn 39, Issue 2, 2014, Pages 291-299

  Kim, Kyung Ah ^a   Kim, Myeong Jin ^b   Choi, Jin Young ^b   Park, Mi Suk ^b   Lim, Joon Seok ^b   Chung, Yong Eun ^b   Kim, Ki Whang ^b  

^a The Catholic University of Korea   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Computed tomography; Gadoxetic acid; Hepatic resection; Hepatocellular carcinoma; Intrahepatic tumor recurrence; Magnetic resonance imaging

Indexed keywords

GADOXETIC ACID;

ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HISTOLOGY; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE;

AGED; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IOHEXOL; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84897582579     PISSN: 09428925     EISSN: 14320509     Source Type: Journal    
DOI: 10.1007/s00261-013-0064-y     Document Type: Article

References (39)

1. Kloeckner R, Otto G, Biesterfeld S, et al. (2010) MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma. Cardiovasc Intervent Radiol 33(3):532-540. doi:10.1007/s00270-009-9728-y
2. Sun HY, Lee JM, Shin CI, et al. (2010) Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (≤2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging. Invest Radiol 45(2):96-103. doi:10.1097/RLI. 0b013e3181c5faf7
3. Choi GH, Kim DH, Kang CM, et al. (2008) Prognostic factors and optimal treatment strategy for intrahepatic nodular recurrence after curative resection of hepatocellular carcinoma. Ann Surg Oncol 15(2):618-629. doi:10.1245/s10434- 007-9671-6
4. Poon RT, Fan ST, Ng IO, et al. (2000) Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 89(3):500-507 (Pubitemid 30640096)
5. Nakashima O, Kojiro M (2001) Recurrence of hepatocellular carcinoma: multicentric occurrence or intrahepatic metastasis? A viewpoint in terms of pathology. J Hepatobiliary Pancreat Surg 8(5):404-409 (Pubitemid 33725570)
6. Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology (Baltimore, MD) 42(5):1208-1236. doi: 10.1002/hep.20933 (Pubitemid 43112690)
7. Chiaramonte M, Stroffolini T, Vian A, et al. (1999) Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer 85(10):2132-2137 (Pubitemid 29215551)
8. Fattovich G, Stroffolini T, Zagni I, Donato F (2004) Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127(5 Suppl 1):S35-S50 (Pubitemid 39423368)
9. Poon RT, Fan ST, Lo CM, Liu CL, Wong J (1999) Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 229(2):216-222 (Pubitemid 30191795)
10. Zhou Y, Sui C, Li B, et al. (2010) Repeat hepatectomy for recurrent hepatocellular carcinoma: a local experience and a systematic review. World J Surg Oncol 8:55. doi:10.1186/1477-7819-8-55
11. Tung-Ping Poon R, Fan ST, Wong J (2000) Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 232(1):10-24
12. Ando E, Tanaka M, Yamashita F, et al. (2003) Diagnostic clues for recurrent hepatocellular carcinoma: comparison of tumour markers and imaging studies. Eur J Gastroenterol Hepatol 15(6):641-648. doi:10.1097/01.meg. 0000059135.68845.70 (Pubitemid 36688229)
13. Ferris JV, Baron RL, Marsh JW Jr, et al. (1996) Recurrent hepatocellular carcinoma after liver transplantation: spectrum of CT findings and recurrence patterns. Radiology 198(1):233-238 (Pubitemid 26008270)
14. Nishizaki T, Takenaka K, Yanaga K, et al. (1997) Early detection of recurrent hepatocellular carcinoma. Hepatogastroenterology 44(14):508-513 (Pubitemid 27171066)
15. Kim SH, Lee J, Kim MJ, et al. (2009) Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 192(6):1675-1681. doi:10.2214/ajr.08.1262
16. Sano K, Ichikawa T, Motosugi U, et al. (2011) Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging. Radiology 261(3):834-844. doi:10.1148/radiol.11101840
17. Bolondi L, Gaiani S, Celli N, et al. (2005) Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology (Baltimore, MD) 42(1):27-34. doi:10.1002/hep.20728 (Pubitemid 40911308)
18. Yu JS, Chung JJ, Kim JH, Kim KW (2008) Large (≥2 cm) nonhypervascular nodules depicted on MRI in the cirrhotic liver: fate and implications. Clin Radiol 63(10):1121-1130. doi:10.1016/j.crad.2008.03.005
19. Chung JJ, Yu JS, Kim JH, Kim MJ, Kim KW (2008) Nonhypervascular hypoattenuating nodules depicted on either portal or equilibrium phase multiphasic CT images in the cirrhotic liver. AJR 191(1):207-214. doi:10.2214/ajr.07.3409,10.2214/ajr.08.1270
20. Grazioli L, Olivetti L, Fugazzola C, et al. (1999) The pseudocapsule in hepatocellular carcinoma: correlation between dynamic MR imaging and pathology. Eur Radiol 9(1):62-67
21. Purysko AS, Remer EM, Coppa CP, et al. (2012) LI-RADS: a casebased review of the new categorization of liver findings in patients with end-stage liver disease. Radiographics 32(7):1977-1995. doi: 10.1148/rg.327125026
22. Huppertz A, Haraida S, Kraus A, et al. (2005) Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT-initial observations. Radiology 234(2):468-478. doi:10.1148/radiol.2342040278 (Pubitemid 40139918)
23. Frericks BB, Loddenkemper C, Huppertz A, et al. (2009) Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA. AJR Am J Roentgenol 193(4):1053-1060. doi:10.2214/ajr.08.1946
24. Krinsky GA, Lee VS, Theise ND, et al. (2001) Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation. Radiology 219(2):445-454. doi:10.1148/radiology.219.2.r01ma40445 (Pubitemid 32336360)
25. Tralhao JG, Dagher I, Lino T, Roudie J, Franco D (2007) Treatment of tumour recurrence after resection of hepatocellular carcinoma. Analysis of 97 consecutive patients. Eur J Surg Oncol 33(6):746-751. doi:10.1016/j.ejso.2006. 11.015 (Pubitemid 47029666)
26. Shimada K, Sano T, Sakamoto Y, Kosuge T (2005) A long-term follow-up and management study of hepatocellular carcinoma patients surviving for 10 years or longer after curative hepatectomy. Cancer 104(9):1939-1947. doi:10.1002/cncr. 21461 (Pubitemid 41513178)
27. Shimozawa N, Hanazaki K (2004) Longterm prognosis after hepatic resection for small hepatocellular carcinoma. J Am Coll Surg 198(3):356-365. doi:10.1016/j.jamcollsurg.2003.10.017 (Pubitemid 38283726)
28. Taura K, Ikai I, Hatano E, et al. (2006) Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection: an analysis of 610 patients over 16 years old. Ann Surg 244(2):265-273. doi:10.1097/01.sla. 0000217921.28563.55 (Pubitemid 44305542)
29. Hwang J, Kim SH, Lee MW, Lee JY (2011) Small (≤2 cm) hepatocellularcarcinoma in patients with chronic liver disease: comparison of gadoxetic acid-enhanced 3.0 T MRI and multiphasic 64-MDCT. Br J Radiol. doi:10.1259/bjr/27727228
30. Baek CK, Choi JY, Kim KA, et al. (2012) Hepatocellular carcinoma in patients with chronic liver disease: a comparison of gadoxetic acid-enhanced MRI and multiphasic MDCT. Clin Radiol 67(2):148-156. doi:10.1016/j.crad.2011.08.011
31. Di Martino M, Marin D, Guerrisi A, et al. (2010) Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the detection of hepatocellular carcinoma in patients with cirrhosis. Radiology 256(3):806-816. doi: 10.1148/radiol.10091334
32. Hayashida M, Ito K, Fujita T, et al. (2008) Small hepatocellular carcinomas in cirrhosis: differences in contrast enhancement effects between helical CT and MR imaging during multiphasic dynamic imaging. Mag Resonance Imaging 26(1):65-71 (Pubitemid 350299721)
33. Kühn J-P, Hegenscheid K, Siegmund W, et al. (2009) Normal dynamic MRI enhancement patterns of the upper abdominal organs: gadoxetic acid compared with gadobutrol. Am J Roentgenol 193(5):1318-1323. doi:10.2214/ajr.09.2412
34. Reimer P, Rummeny EJ, Shamsi K, et al. (1996) Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 199(1):177-183 (Pubitemid 26098637)
35. Zech CJ, Herrmann KA, Reiser MF, Schoenberg SO (2007) MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA. Mag Reson Med Sci 6(1):43-52
36. Granito A, Galassi M, Piscaglia F, et al. (2012) Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the noninvasive diagnosis of small hepatocellular carcinoma: a prospective study. Aliment Pharmacol Ther. doi:10.1111/apt.12166
37. Marin D, Di Martino M, Guerrisi A, et al. (2009) Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section CT. Radiology 251(1):85-95. doi:10.1148/radiol.2511080400
38. Ahn SS, Kim MJ, Lim JS, et al. (2010) Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma. Radiology 255(2):459-466. doi:10.1148/radiol.10091388
39. Golfieri R, Renzulli M, Lucidi V, et al. (2011) Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to dynamic MRI in the detection of hypovascular small (≤2 cm) HCC in cirrhosis. Eur Radiol 21(6):1233-1242. doi:10.1007/s00330-010-2030-1